Amneal Pharmaceuticals, Inc.
AMRX
$7.48
$0.060.81%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 19.92% | -16.07% | -58.08% | -67.26% | 237.24% |
| Total Receivables | 25.23% | 7.53% | 12.56% | 20.62% | -18.93% |
| Inventory | 5.34% | 3.45% | 4.55% | 7.87% | 9.54% |
| Prepaid Expenses | -6.08% | 2.93% | 35.04% | 28.84% | 5.07% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 4.01% | -50.00% | 10.48% | -20.30% | -22.42% |
| Total Current Assets | 15.24% | 3.93% | 4.48% | 5.56% | -2.41% |
|
|
|||||
| Total Current Assets | 15.24% | 3.93% | 4.48% | 5.56% | -2.41% |
| Net Property, Plant & Equipment | -4.81% | -4.98% | -7.41% | -5.81% | -6.66% |
| Long-term Investments | -0.20% | -0.05% | -0.11% | -0.10% | -0.04% |
| Goodwill | -0.20% | -0.05% | -0.11% | -0.10% | -0.04% |
| Total Other Intangibles | -17.75% | -20.59% | -19.25% | -18.58% | -18.76% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 31.39% | 24.67% | 80.47% | 39.72% | 4.52% |
| Total Assets | 0.83% | -6.13% | -5.16% | -4.69% | -8.60% |
|
|
|||||
| Total Accounts Payable | 78.55% | 33.55% | 44.62% | 29.25% | -12.77% |
| Total Accrued Expenses | 24.92% | 16.00% | 16.39% | 32.50% | 12.74% |
| Short-term Debt | -44.13% | 84.21% | 49.17% | 79.00% | 198.33% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 394.11% | 418.19% | 486.63% | 9.73% | 8.93% |
| Total Finance Division Other Current Liabilities | -2.23% | -9.97% | -20.02% | -21.18% | -13.56% |
| Total Other Current Liabilities | -2.23% | -9.97% | -20.02% | -21.18% | -13.56% |
| Total Current Liabilities | 33.45% | 43.99% | 43.35% | 18.57% | 12.46% |
|
|
|||||
| Total Current Liabilities | 33.45% | 43.99% | 43.35% | 18.57% | 12.46% |
| Long-Term Debt | -10.94% | -16.00% | -15.92% | -7.00% | -7.76% |
| Short-term Debt | -44.13% | 84.21% | 49.17% | 79.00% | 198.33% |
| Capital Leases | -4.56% | -5.36% | -6.44% | -8.12% | -12.28% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 291.01% | 156.62% | 160.60% | 130.62% | -56.99% |
| Total Liabilities | 3.95% | -0.03% | -0.11% | 0.25% | -4.99% |
|
|
|||||
| Common Stock & APIC | 3.87% | -22.57% | -22.85% | -23.01% | -21.93% |
| Retained Earnings | -23.85% | -47.11% | -43.52% | -40.83% | -20.68% |
| Treasury Stock & Other | -102.51% | -2,005.03% | -476.54% | -729.94% | -425.48% |
| Total Common Equity | -652.38% | -128.24% | -118.06% | -121.64% | -93.37% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -652.38% | -128.24% | -118.06% | -121.64% | -93.37% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 55.89% | 142.84% | 139.47% | 135.64% | 146.40% |
| Total Equity | -172.65% | -117.60% | -102.22% | -110.24% | -70.66% |
|
|
|||||